The smallest pacemaker in the world has just received official regulatory approval.
News & Analysis: Medtronic
The Super Bowl of healthcare kicked off early for these companies.
The high-profile medical device specialist is the proud new owner of Stimgenics.
A significant correction is an inevitability at some point, if history is any guide. Here are three stocks to buy if the opportunity arises.
Investors counting on the company's dominance of the closed-loop artificial pancreas market might want to temper their expectations.
These stocks offer investors a mix of stability, growth, and value.
The medical device giant has enjoyed a lot of growth outside the U.S.
MDT earnings call for the period ending September 30, 2019.
The medical device maker posted another solid quarter and has high hopes for product launches on the way.
Medtronic touts an admirable run of increasing its dividend over 42 consecutive years. But, is the dividend enough for investors to get excited today?